Use the search parameters below to filter talks:

2010 - TTS International Congress (Vancouver)

Clinical Islet Transplantation
16 August 2010  /  15:30 - 16:59
Islet Allograft Survival in Type 1 Diabetic Patients Using Calcineurin Inhibitor-free Protocols Based on T-Cell Adhesion or Costimulation Blockade
Presenter: Andrew Posselt, United States

Immune Regulation and Tolerance II
17 August 2010  /  00:00 - 00:01
Bcl-2 inhibition: a new concept to prevent solid allograft rejection
Presenter: Pietro Cippa, Switzerland
Prevention of skin graft rejection by specific induction of apoptosis of host APC presenting graft-derived antigens
Presenter: elke Giets, Belgium
A novel immunosuppressive agent, DTCM-glutarimide markedly prolongs cardiac allograft survival in mouse when combined with Donor specific transfusion
Presenter: Yusuke Tsunetoshi, Japan
A Quantitative Proteomics Approach For Identification of Potential Biomarkers In Transplant Tolerance
Presenter: Jihong Wang, Canada
DAP12 Controls STAT3 Activation in ‘Tolerogenic ‘ Liver Dendritic Cells
Presenter: Angus Thomson, United States
Immunomodulatory interactions between mesenchymal stem cells and regulatory T cells after kidney transplantation
Presenter: Carla Baan, Netherlands
The Role of Mesenchymal Stem Cells in Stabilizing Pancreatic Islet Cell Transplant in Mice
Presenter: Clara Tan-Tam, Canada

International Trends in Organ Donation
17 August 2010  /  00:01 - 00:02
Excellent Long-term Outcomes of Kidney Transplantation Using Kidneys from Deceased Donors with Acute Kidney Injury
Presenter: North Techawathanawanna, Thailand
Liver transplantation with donor aged 70 or above: is it justified?
Presenter: Bjoern Wellge, Germany
Validation of the Kidney Donor Risk Index (KDRI) Score in a UK Single Centre DCD Cohort
Presenter: James Pine,
Trends in organ donation in the UK
Presenter: Rachel Johnson,
The possibilities of improving procurement activity in Slovakia (Five years analyses of deaths in region with 865000 people)
Presenter: Juraj Miklušica, Slovakia (Slovak Republic)
Professional experience of Critical Care staff impacting on comfort levels with donation related tasks.
Presenter: Leo Roels, Belgium
Extended Pancreas Donor Program - The EXPAND Study
Presenter: Stefan Farkas, Germany
Lifetime Probabilities of Needing an Organ Transplant versus Donating an Organ after Death
Presenter: Laura Hornby, Canada
Changes in practice and its effect on the coordination of the organ donation process in Québec: an analysis of the current situation
Presenter: Sylvain Lavigne, Canada
Donor age related conversion rates in 5 European countries: Donor Action® evidence based data demonstrating an unexploited potential
Presenter: Leo Roels, Belgium

New Immunosuppressive Agents
17 August 2010  /  00:02 - 00:04
Safety Profile Of Tasocitinib (CP-690,550)-Based CNI-Free Regimens In De Novo Kidney Transplant Patients In A Dose/Exposure-Finding Phase 2B Study: Results Of A 6-Month Interim Analysis
Presenter: Helio Tedesco-Silva, Afghanistan
Correlation Of Tasocitinib (CP-690,550) And MPA Pharmacokinetics With Clinical Events In De Novo Kidney Transplant Patients: Preliminary Results From A Phase 2B Study
Presenter: Philip O’Connell, Australia

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada

Info

Privacy Policy
Terms of Use
Copyright Notice